Summary
Updated Aug 30, 2026
Steven R. Altman is Director of DEXCOM INC (DXCM). 3 SEC Form 4 filings on record going back to 2025, most recently on 1 June 2026.
Recent Transactions
6Every recent SEC Form 4 transaction Steven R. Altman has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Steven R. Altman files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Kevin R. Sayer - $8.30M of DXCM open-market activity in the last 12 months
- Jacob Steven Leach - $1.00M of DXCM open-market activity in the last 12 months
- Michael Jon Brown - $730K of DXCM open-market activity in the last 12 months
- Jon Coleman - $723K of DXCM open-market activity in the last 12 months
- Mark G. Foletta - $627K of DXCM open-market activity in the last 12 months
- Richard Alexander Collins - $389K of DXCM open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Steven R. Altman?
Steven R. Altman is a corporate insider, tracked as Director of DEXCOM INC (DXCM). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Steven R. Altman submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Where can I see all of Steven R. Altman's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Steven R. Altman and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial